Mifeprex Label Allows Use By Physicians Not Trained In Surgical Abortion

The Population Council and Danco Labs will conduct a postmarketing safety study to compare outcomes for Mifeprex (mifepristone) patients treated by physicians trained in surgical abortion versus those treated by physicians not trained in abortion.

More from Archive

More from Pink Sheet